Successful implantation is associated with a unique spatial pattern of vascular remodeling, characterized by profound peripheral neo-vascularization surrounding a periembryo avascular niche. We hypothesized that hyaluronan controls the formation of the unique vascular pattern encompassing the embryo. This hypothesis was evaluated by genetic modification of hyaluronan metabolism specifically targeted to embryonic trophoblast cells. The outcome of altered hyaluronan deposition on uterine vascular remodeling and post-implantation development were analyzed by MRI, detailed histological examinations, and RNA-sequencing of uterine NK cells. Our experiments revealed that eliminating the anti-angiogenic hyaluronan, led to elevated expression of MMP-9, VEGF-A and its receptor VEGFR-2, accompanied by reduced recruitment of uterine NK cells. Further local decrease in VEGFR-3 resulted in impaired formation of vascular sinuous folds, ectopic angiogenesis and dysfunctional uterine NK cells.
Introduction
The birth of a properly developed mammalian offspring requires the fulfillment of a series of complex, highly regulated processes, initiated by embryo implantation and placental formation concomitant with uterine decidualization, followed by proper fetal development culminating by parturition. A timely and coordinated sequence of these events is subjected to regulation by ovarian steroid hormones, estrogen and progesterone 1 . In humans, the success of natural conception per menstrual cycle is low (~30%), and implantation defects were implicated in 75% of failed pregnancies 2 3 .
The general principles of implantation are well conserved among mammals. Implantation occurs at the blastocyst stage, at which the first cell lineages form 4 . The blastocyst contains an inner cell mass, which mainly gives rise to the fetal organs, and the trophectoderm, an outer epithelial-like cell layer, which attaches to the uterine epithelium. The trophectoderm invades, in turn, the underlying stroma to form the extraembryonic ectoderm and the ecto-placental cone 5 , further developing into the hemochorial placentae 6, 7 . Implantation in mice, which takes place at embryonic day 4.5 (E4.5) starts with blastocyst apposition and its attachment to the uterine epithelium, to trigger decidualization of the uterine stromal cells, characterized by rapid cellular proliferation and differentiation. Secretion of VEGF-A by the decidual cells and induction of VEGF-VEGFR-2 signaling 8, 9 , result in an immediate local increase in vascular permeability followed by the expression of CD34, an endothelial marker for angiogenesis 10 . This neovascularization event, takes place in the anti-mesometrial pole of the decidua, the site of initial trophoblast invasion and is governed by the progesterone-progesterone receptor axis 8 . The newly formed vessels continue to increase in number and diameter, to supply the embryo with oxygen and nutrients, necessary for its survival and rapid growth 11 . The decidual mesometrial pole, on the other hand, is characterized by the development of vascular sinuous folds (VSFs), which are arterio-venous vascular shunts, markedly enlarged and elongated prior to placentation 8 . Another receptor for VEGF signaling, VEGFR-3, participates in this orchestrated series of events as an attenuator of vascular permeability by inhibiting VEGFR-2 expression, consequently blocking VEGF-VEGFR-2 induced permeability 12, 13 . Perturbation of vascular remodeling during early pregnancy is associated with pathologies, often detected at later stages of gestation, including firsttrimester miscarriages, preeclampsia, placental failure and intrauterine growth restriction 8 .
In addition to these strictly controlled angiogenic events, the effective delivery of maternal supply to the embryo is absolutely dependent on the formation of two decidual sub-compartments at E6.5; the highly vascularized secondary decidual zone at the decidual rim, and the avascular primary decidual zone, adjacent to the embryo. This spatially regulated growth of vessels, together with the embryonic diffusion barrier, form the hypoxic niche of the peri-implantation embryo 14 . This barrier enables maternal nourishing of the embryo while avoiding its immediate exposure the maternal circulation, thus 15 controlling the delivery of blood-borne high molecular-weight contents, including immune cells and immunoglobulins. 1, 16 . The mechanism underlying the formation of this diffusion barrier is poorly understood.
Prior to placentation, the decidua, is enriched with a large population of leukocytes, comprised mainly of uterine NK cells, accounting for 70% of the decidual stroma 17 .
Interestingly, in both humans as well as mice, the functions of uterine NK cells differ profoundly from peripheral NK cells. Namely, unlike the predominant cytotoxic actions against virus-infected or cancerous cells, characteristic to peripheral NK cells, the uterine subsets show differential effector repertoire and vessel remodeling activities 15,18 17 .
Moreover, uterine NK cells, have been demonstrated to regulate 'ligand-independent' VEGFR-3 coordination of enlargement and elongation of VSFs via pruning of mesometrial vasculature 8 .
Blastocyst adhesion to the uterine lining, a necessary prelude for implantation, is facilitated by delicate paracrine and juxtacrine interactions. The latter are characterized mainly by extra-cellular matrix (ECM) components, including specific mucins, selectins, integrins, and glycosaminoglycans, such as heparan sulfate and hyaluronan 2 . During trophoblast invasion, uterine epithelial cells locally undergo apoptosis and are phagocytosed by primary trophoblast giant cells. The subsequent basement membrane degradation enables the establishment of direct contacts between invading trophoblast cells and the endometrial stroma, including uterine decidual cells, decidual blood vessels and their supporting ECM 19 . Following trophectoderm invasion, of the anti-mesometrial pole of the uterine lumen 19 , the ECM undergoes extensive transformations, including generation of an interrupted and thickened basement membrane within the peri-cellular spaces of the post-implantation decidua. The latter may confine infiltration of immune cells, or block exposure to maternal antibodies, to sin the frame of primary maternal tolerance 20 . Trophoblast invasion is facilitated by trophectoderm cells-produced proteinases, such as MMP-9, and urokinase-type plasminogen activator 2 , that modify the ECM and possibly exploit uterine ECM remodeling, including rapid endometrial hyaluronan clearance 21 .
Hyaluronan is a negatively charged un-branched cell-surface associated polysaccharide, In the study presented here, the role of hyaluronan as a vascular morphogen shaping the primary maternal-embryo barrier was evaluated during implantation and early mouse pregnancy. To this end, we employed lentivirus-mediated genetic modification of hyaluronan metabolism, directed at the embryonic trophectoderm. We report herein that disruption of hyaluronan synthesis, as well as its increased cleavage, at the embryonic niche, impairs implantation by induction of decidual vascular permeability, defective VSF formation and breach of the maternal-embryo barrier. This phenotype was associated with elevated MMP-9 expression and interrupted uterine NK cells recruitment and function. Conversely, enhanced deposition of hyaluronan resulted in the expansion of the maternal-embryo barrier and increased diffusion distance, leading to compromised implantation. We also demonstrate that deposition of hyaluronan at the embryonic niche is subjected to regulation of the PR. These results demonstrate a pivotal role for hyaluronan in the success of pregnancy by fine-tuning the peri-embryo vascular morphogenesis, so as to maintain the primary maternal-embryo vascular barrier and the hypoxic avascular niche, during early pregnancy.
Results

Decidual angiogenesis mirrors spatially and temporally the pattern of deposition of hyaluronan and its degradation products
Following embryo implantation, the uterus undergoes rapid and profound tissue remodeling ( Figure 1A) . The previously reported induction of angiogenesis 10 is herein indicated by CD34, a marker for newly formed blood vessels observed in the antimesometrial pole of the decidua (Figure 1B) . This vascular modification coincided spatially and temporally with dynamic alterations in the deposition of hyaluronan after implantation. Specifically, following implantation (E5.5), hyaluronan accumulated in the mesometrial poleand surrounding the embryo. At E6.5 hyaluronan was mainly deposited in the ecto-placental cone in mesometrial orientation to the implantation chamber ( Figure   1C ). Accumulation of hyaluronan oligosaccharides was detected in pregnant mice following embryo implantation, in concomitance intensified decidual angiogenesis ( Figure 1D ).
To further explore hyaluronan deposition we analyzed the distribution of hyaluronan synthases, hyaluronidases and hyaluronan binding proteins throughout the periimplantation period. We found that the hyaluronan synthesizing enzyme, HAS-1 was locally up-regulated in implantation sites at E4.5, transiently decreasing at E5.5, and increasing again at E6.5 ( Figure S2A) . Interestingly, the expression of HAS-2 continuously decreased during the post-implantation period (Figure S2B ). Hyal-1 expression underwent gradual down-regulation ( Figure S2C) , whereas the expression levels of Hyal-2 remained stable throughout implantation ( Figure S2D) . We also analyzed the expression pattern of two hyalhedrines, hyaluronan ECM stabilizing glycoproteins, TSG-6 and Versican. TSG-6 was significantly up-regulated on the day of implantation, followed by a sharp reduction in its expression ( Figure S2E) , whereas Versican expression levels remained constant during the two consecutive days following blastocyst attachment and invasion ( Figure S2F) .
For further resolution, we examined the spatio-temporal distribution of hyaluronan biosynthesis enzymes in the different decidual sub-compartments ( Figure S2G ).
Not surprisingly, two of the receptors for hyaluronan oligosaccharides, CD44 and LYVE-1 22 , were co-expressed with HAS-2 and the two Hyaluronidases. After the day of implantation, both CD44 and LYVE-1 showed a pattern of expression similar to that of Hyal-2 and Hyal-1 (Figure 2D& Figure S2H ). Interestingly, RHAMM, a hyaluronan mediated motility receptor, was highly expressed by the maternal decidualized cells, in a ring-like structure at E5.5 and virtually absent at E6.5 ( Figure S2I ).
Overall, we show the close spatial association of hyaluronan bio-synthesis, enzymatic degradation and receptors at the feto-maternal interface post-implantation.
Progesterone receptor signaling positively regulated hyaluronan degradation, trophoblast invasion and decidual angiogenesis
To examine the involvement of progesterone in hyaluronan metabolism, we suppressed PR signaling via single administration of its antagonist, RU486, at E4.5, postimplantation (8 mg/kg BW). Interestingly, RU486 treatment led to decreased expression of Hyal-2 and impaired anti-mesometrial stromal invasion by primary trophoblast giant cells, at E5.5 ( Figure 3C&D) . As previously demonstrated for later pregnancy 8 , RU486
administration after initial decidualization, resulted in a decreased VEGF-A expression ( Figure 3A) , accompanied by resorptions of embryos ( Figure 3B ).
Hyal-2 over-expression in trophoblast cells disrupted the hyaluronan maternalembryo barrier, leading to embryo resorption
To study the role of hyaluronan at the feto-maternal interface, post-implantation, we generated blastocysts expressing eGFP in their trophectoderm cells along with overexpression of Hyal-2, using lentiviral infection ( Figure 4A ).
Prior to their transfer to pseudo-pregnant recipient mice, the blastocysts were visualized for eGFP expression. Notably, fluorescence was restricted to the trophectoderm, and could not be detected in the ICM (Figure 4B&D) . Transgene over-expression was validated by immunofluorescence of infected embryos ( Figure 4C&E 
Hyal-2 over-expression in trophoblast cells resulted in impaired uterine NK cells recruitment and function
Uterine NK cells were detected in the mesometrial pole of E6.5 decidua and flanking trophoblast giant cells ( Figure 7A) . The latter demonstrated the potential of binding 
HAS-2 over-expression in trophoblast cells resulted in decreased permeability of decidual blood vessels, leading to early embryonic lethality
To further confirm the contribution of hyaluronan metabolism to the success of implantation, lentiviral blastocyst infection was also employed for HAS-2 overexpression (HAS-2 OEx). As expected, the deposition of peri-embryo hyaluronan was enhanced upon the transfer of these blastocysts to pseudo-pregnant mice (Figure 4) .
Nevertheless, while no effect on infiltration of inflammatory macrophages or on the number of implantation sites (Figure 9D-F Due to the classical role of hyaluronan as a biological glue 22 , it has been hypothesized that it facilitates attachment of the pre-implantation embryo. This claim was supported by enhanced attachment of isolated, pre-implantation blastocysts to hyaluronan-rich matrix 43 and further challenged by the use of hyaluronan-enriched blastocyst transfer medium with the aim of improving blastocyst adherence 44 . Interestingly, Hyal-2 over-expression enhanced implantation rate. This observation may reflect the potency of low-molecularweight hyaluronan to induce cellular motility and invasion, as previously described for tumor cells, fibroblasts and endothelial cells 34, 45-47 48 . Along this line, RHAMM, a receptor for low molecular-weight hyaluronan, which is an efficient mediator of tumor cell invasion 49 As a whole, our study shows that hyaluronan acts as an ECM-based dynamic mediator of the primary maternal-embryo barrier for the developing embryo prior to placentation and is crucial for decidual morphogenesis. Furthermore, our findings highlight a critical role for hyaluronan as a vascular morphogen, which acts via recruitment and function of uterine NK cells, in the frame of gestational vascular adaptations. These findings implicate hyaluronan metabolism as a key regulator for the successful establishment of pregnancy.
Methods
Animals. C57Bl/6J female mice (6-12 week old; Envigo, Israel) were mated with Myr-Venus homozygote males 51 . These hemizygote Myr-Venus embryos were used for histological analysis of hyaluronan metabolism. ICR males and females (8) (9) (10) (11) (12) week old;
Envigo) were mated and assessed for the occurrence of vaginal plugs on the following day. These mice were used for gene expression analysis during early pregnancy, as well as for MRI experiments. All mice were maintained under specific pathogen-free conditions and handled under protocols approved by the Weizmann Institute Animal Care and Use Committee according to international guidelines.
Immunohistochemistry (see Supplementary material).
Gene expression analysis. RNA extraction was performed according to manufacturer's protocol (PerfectPure RNA tissue kit, 5 Prime; Gaithersburg, MD, USA) for all analyses.
Then, cDNA production followed the manufacturer's protocol with the High Capacity 
Progesterone receptor pharmacological blockade
Pregnant mice (late E4.5) were administered intraperitoneally with RU486 (8mg/kg, Sigma-Aldrich), sacrificed at E5.5 and their uteri examined via histological analyses.
Generation of transgenic trophoblasts in murine blastocysts. Lentiviral vectors design
and production. Lentiviral vectors were constructed to produce lentiviruses expressing mouse Hyaluronidase-2 (Hyal-2), and mouse Hyaluronan synthase-2 (HAS-2). Mouse
Hyal-2 (GeneBank accession No. NM_010489.2) was isolated from uterine cDNA by PCR using a sense primer carrying a Human influenza hemagglutinin (HA) tag and restriction sites for AgeI and the anti-sense primer for SfiI (Supplementary Table 2 ).
Mouse HAS-2 (GeneBank accession No. NM_008216.3) was isolated from uterine cDNA by restriction-free cloning, using primers containing complementary overhangs to the designated target vector (Supplementary Table 2 ). The purified PCR products were Table 3 ) according to manufacturer's protocol (Takara Bio USA, Inc.
California, U.S.A). NK cell Libraries were prepared as previously described 54 . In brief, 20000 NCR1+ cells were sorted into 40µl of lysis/binding buffer, from which, mRNA was captured with 12 ml of Dynabeads oligo(dT) (Dynabeads™ mRNA DIRECT™ Purification Kit, NY, USA), washed, and eluted at 85C with 10 ml of 10 mM Tris-Cl (pH 7.5) and processed according to protocol previously developed for single-cell RNA-seq 54 . In brief, the samples were barcoded, converted to cDNA, pooled and linearly amplified by T7 in vitro transcription. mRNA was then fragmented and converted into a sequencing-ready library, which is then tested for quality and concentration 54 . MARS-seq libraries were sequenced using an Illumina NextSeq 500 sequencer, at a sequencing depth of ~ 5 million reads per sample.
Validation of gene over-expression. ES-2 cells, ovarian
Statistics. All statistical analyses used in this study were two-tailed with a similar level of significance (p=0.05), and demonstrated normal values distribution. Beside the on-way ANOVA analysis conducted for gene expression analysis of hyaluronan metabolism during implantation (Figure S1) , all statistical analysis were examined by t tests, while assuming homogenous distribution of variances. All statistical analyses were conducted using GraphPad Prism 7(CA, USA).
Bioinformatic analysis. MARS-seq analysis was done using the UTAP transcriptome analysis pipeline 55 at the bioinformatics unit. Reads were trimmed using cutadapt (DOI: ELISA. Embryo implantation sites were harvested from foster dams at E6. 
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